| Record ID | marc_columbia/Columbia-extract-20221130-032.mrc:145512450:3518 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-032.mrc:145512450:3518?format=raw |
LEADER: 03518cam a2200697 i 4500
001 15815818
005 20220326231549.0
006 m o d
007 cr cnu---unuuu
008 131014s2013 enk eob 001 0 eng d
035 $a(OCoLC)ocn860711177
035 $a(NNC)15815818
040 $aN$T$beng$erda$epn$cN$T$dOCLCF$dTYFRS$dYDXCP$dOCLCQ$dOCLCA$dNLE$dAU@$dUKMGB$dUKAHL$dOCLCQ$dLEAUB$dK6U$dOCLCO$dOCLCQ$dOCLCO
015 $aGBB6G9417$2bnb
016 7 $a017501256$2Uk
019 $a1086539010
020 $a9781135072896$q(electronic bk.)
020 $a1135072892$q(electronic bk.)
020 $a9780203597712$q(e-book ;$qPDF)
020 $a0203597710
020 $a9781135072902$q(e-book ;$qPDF)
020 $a1135072906
020 $a9781135072889$q(e-book ;$qMobi)
020 $a1135072884
020 $a9780415815642$q(paperback)
020 $a0415815649
020 $z9780415815628
020 $z0415815622
035 $a(OCoLC)860711177$z(OCoLC)1086539010
037 $a9781135072896$bIngram Content Group
043 $an-us---
050 4 $aHV6769
072 7 $aBUS$x070000$2bisacsh
082 04 $a338.476151$223
049 $aZCUA
100 1 $aBraithwaite, John,$d1951-
245 10 $aCorporate crime in the pharmaceutical industry /$cJohn Braithwaite.
264 1 $aLondon :$bRoutledge,$c2013.
300 $a1 online resource (viii, 440 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aRoutledge revivals.
500 $aOriginally published in 1984 by Routledge & Kegan Paul.
504 $aIncludes bibliographical references and index.
520 $aFirst published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
588 0 $aPrint version record.
505 0 $a1. Introduction : an industry case study of corporate crime -- 2. Bribery -- 3. Safety testing of drugs : from negligence to fraud -- 4. Unsafe manufacturing practices -- 5. Antitrust -- 6. The corporation as pusher -- 7. Drug companies and the Third World -- 8. Fiddling -- 9. Strategies for controlling corporate crime.
650 0 $aPharmaceutical industry$xCorrupt practices.
650 0 $aCommercial crimes.
650 6 $aIndustrie pharmaceutique$xPratiques déloyales.
650 6 $aInfractions économiques.
650 7 $aBUSINESS & ECONOMICS$xIndustries$xGeneral.$2bisacsh
650 7 $aCommercial crimes.$2fast$0(OCoLC)fst00869469
650 7 $aPharmaceutical industry$xCorrupt practices.$2fast$0(OCoLC)fst01060133
655 4 $aElectronic books.
655 7 $aCase studies.$2fast$0(OCoLC)fst01423765
776 08 $iPrint version:$aBraithwaite, John, 1951-$tCorporate crime in the pharmaceutical industry$z9780415815628$w(OCoLC)826822121
830 0 $aRoutledge revivals.
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15815818$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS